SLGN compared with COLL: revenue, margins and what each company keeps, and the suppliers and customers both name

SLGNSilgan Holdings Inc

Mkt capRevenueRevenue

COLLCollegium Pharmaceutical, Inc

Mkt capRevenueRevenue

Compare

SLGNSilgan Holdings Inc

COLLCollegium Pharmaceutical, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SLGN2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.7%▲+2.58%×0.46

Q2 FY26—▼−3.73%—

COLL

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26thin chain±20.4%▲+6.29%×0.31

Q2 FY26±12.2%▼−18.55%×1.52

= impliedSLGN realized, solidCOLL realized, hatchedOne scale, both sides: full bar = 21%× = |realized| ÷ impliedspan: SLGN 92d · COLL 252dSource: market data

May 7 '26±12.6%▲+7.72%×0.61

Q1 FY26±7.7%▼−3.34%×0.43

SLGNSilgan Holdings Inc

41.12▼−1.25%· post 41.12

Mkt cap$4.3BRevenue$2.0BQ3 FY26Revenue$6.5BFY25

COLLCollegium Pharmaceutical, Inc

24.23▼−3.71%· post 24.23

ClosedNov 6 '26

Mkt cap$752.3MRevenue$216MQ3 FY26Revenue$781MFY25

Compare

ClosedNov 6 '26

SLGNSilgan Holdings Inc

COLLCollegium Pharmaceutical, Inc

41.12▼−1.25%post 41.12

Price

24.23▼−3.71%post 24.23

$4.3B

Mkt cap

$752.3M

Q3 FY26$2.0B

Revenue

$216MQ3 FY26

FY25$6.5B

Revenue

$781MFY25

SLGN41.12▼−1.25%vsCOLL24.23▼−3.71%ClosedNov 6 '26